SUBOXONE by Indivior is naloxone. Approved for opioid dependence. First approved in 2002.
Drug data last refreshed 16h ago · AI intelligence enriched 1mo ago
SUBOXONE is a sublingual tablet containing buprenorphine and naloxone, approved in 2002 for opioid use disorder treatment. It works by partial agonism at opioid receptors, reducing cravings and withdrawal symptoms while minimizing abuse potential. The combination formulation is designed to discourage misuse through the naloxone antagonist component.
Product approaching loss of exclusivity with moderate Medicare spending; commercial teams likely focused on generic transition planning and market defense strategies.
naloxone. Buprenorphine is a partial agonist at the mu-opioid receptor and an antagonist at the kappa-opioid receptor. Naloxone is a potent antagonist at mu opioid receptors and produces opioid withdrawal signs and symptoms in individuals physically dependent on full opioid agonists when…
Usability of Zubsolv Sublingual Tablets 5.7/1.4 to Suboxone Sublingual Film 8/2 In Buprenorphine/Naloxone Treated Opioid Dependent Population
Single Dose Pharmacokinetics of Suboxone Study in Hepatic Impaired Subjects
Transfer of Subjects From Subutex/Suboxone to RBP-6300
Multicentre Trial of Suboxone in Opiate-dependent Subjects in Taiwan
Acceptability and Safety of Switching From Subutex or Other Opioid Drug Dependence Therapy to Suboxone (NIS P05444)
Worked on SUBOXONE at Indivior? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Upgrade to Pro to access Medicare Part D spending data and other premium pharma intelligence.
Upgrade to Pro — $25/moWorking on SUBOXONE offers limited growth trajectory given imminent LOE and zero active linked job openings. Career value lies in specialty managed markets expertise, regulatory affairs, or supply chain optimization in a declining commercial environment.